Testing effectiveness (Phase 2)Study completedNCT02733159
What this trial is testing
Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2
Who this might be right for
Carcinoma, Non-Small-Cell Lung
University of Birmingham 62